Atlas Trials

Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Clinical trial NCT01561014 · COMPLETED

Trial details

NCT number
NCT01561014
Sponsor
Wake Forest University Health Sciences
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionAdenocarcinoma of the StomachSquamous Cell Carcinoma of the EsophagusStage II Esophageal CancerStage II Gastric CancerStage III Esophageal CancerStage III Gastric Cancer
Start date
2007-04-01
Primary completion
2009-03-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.